Centre for Haemostasis and Thrombosis, St Thomas' Hospital, London, UK.
Haemophilia. 2010 Nov;16(6):937-42. doi: 10.1111/j.1365-2516.2010.02330.x.
Coagulation factor V (FV) has an important role in the blood coagulation cascade, in both the pro- and anticoagulant pathways. FV deficiency is a rare bleeding disorder with variable phenotypic expression. We report a cohort of 10 patients with mild-severe FV deficiency in whom a total of 11 novel mutations were identified. Three patients were compound heterozygous for two mutations, whereas each of the remaining patients had a single heterozygous variant. FV levels did not correlate with either the type of mutation identified or the bleeding diathesis exhibited by the patients. Although considered to have an autosomal recessive mode of inheritance, patients with a single missense mutation may present with a significant bleeding history. The addition of a significant number of previously unidentified mutations to the public domain will contribute to the knowledge and understanding of the molecular pathology of this rare disorder.
凝血因子 V(FV)在血液凝固级联中具有重要作用,无论是在促凝途径还是抗凝途径中。FV 缺乏症是一种罕见的出血性疾病,具有不同的表型表达。我们报告了 10 例轻重度 FV 缺乏症患者,共发现 11 种新的突变。3 例患者为两种突变的复合杂合子,而其余患者各有一个单杂合变异。FV 水平与所鉴定的突变类型或患者的出血倾向均无相关性。尽管被认为是一种常染色体隐性遗传模式,但具有单个错义突变的患者可能会出现明显的出血史。将大量以前未被识别的突变添加到公共领域将有助于了解和理解这种罕见疾病的分子病理学。